Screening of Inhibitory Activity of Medicinal Plants against Heparinase |
Ahn, Soon-Cheol
(Korea Research Institute of Bioscience and Biotechnology (KRIBB))
Kim, Bo-Yeon (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Oh, Won-Keun (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Lee, Myung-Sun (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Bae, Eun-Young (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Kang, Dae-Wook (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) Ahn, Jong-Seog (Korea Research Institute of Bioscience and Biotechnology (KRIBB)) |
1 | Hulett, M. D., Freeman, C., Hamdorf, B. J., Baker, R. T, Harris, M. J. and Parish, C. R. (1999) Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nature Med. 5: 803-809 DOI ScienceOn |
2 | Bashkin, P., Doctrow, S., Klagsbrun, M., Svahn, C. M., Folkman, J. and Vlodavsky, I. (1989) Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparinase and heparin-like molecules. Biochemistry 28: 1737-1743 DOI ScienceOn |
3 | Takatsu, T., Takahashi, M., Kawase, Y., Enokita, R., Okazaki, T., Matsukawa, H., Ogawa, K., Sakaida, Y., Kagasaki, T., Kinoshita, T., Nakajima, M. and Tanzawa, K. (1996) A-72363 A-l, A-2, and -C, novel heparanase inhibitors from Streptomyces nobilis SANK 60912. I. Taxonomy of producing organism, fermentation, isolation, and structure elucidation. J. Antibiotics 49: 54-60 DOI ScienceOn |
4 | Miao, H., Elkin, M., Aingom, E., Ishai-Michaeli, R., Stein, A. C. and Vlodavsky, I. (1999) Inhibition of heparanase activity and tumor metastasis by laminahn sulfate and synthetic phosphorothioate oligodeoxynucleotides. Int. J. Cancer 83: 424-431 DOI ScienceOn |
5 | Ko, H. R., Kim, B. Y, Oh, W. K., Kang, D. O., Ahn, S. C., Mheen, T. I. and Ahn, J. S. (2000) CRM646-A and B, Novel fungal metabolites that inhibit hepaiinase. J. Antibiotics 53: 384-387 |
6 | Kussie, P. H., Hulmes, J. D., Ludwig, D. L., Patel, S., Navarro, E. C., Seddon, A. P., Giorgio, N. A. and Bohlen, P.(1999) Cloning and functional expression of a human heparanase gene. Biochem. Biophys. Res. Commun. 261: 183-187 DOI ScienceOn |
7 | Moscatelli, D. (1988) Metabolism of receptor-bound and matrix-bound basic fibroblast growth factor by bovine endothelial cells. J. Cell Biol. 107: 753-759 DOI PUBMED ScienceOn |
8 | Ihrcke N. S., Parker, W., Reissner, K. J. and PlaC, J. L. (1998) Reguladon of platelet heparanase during inflammation: Role of pH and proteinases. J. CeII. Physiol. 175: 255-267 DOI ScienceOn |
9 | Bame K.J. (2001) Heparanases: Endoglycosidases that degrade heparan sulfate proteoglycans. GIycobiotogy 11: 91R-98R |
10 | Bernfield, M., Gotte, M., Park, P. W., Reizes, O., Fitzgerald, M. L., Lincecum, J. and Zako, M. (1999) Functions of cell surface heparan sulphate proteoglycans. Ann. Rev. Biochem. 68: 719-777 |
11 | Herr, B. A., Qrnitz, M. D., Sasisekharan, R., Venkataraman, G. and Waksman, G. (1997) Heparin-induced self-associa tion offibroblast growth factor-2. J. Biot. Chem. 272: 16382-16389 DOI |
12 | Nakajima, M., Dechavingy, A., Johnson, C. E., Hamada, J., Stein, C. A. and Nicolson, G. L. (1991) Suramin: a potent inhibitor of melanoma heparanase and invasion. J. Biol. Chem. 266: 9661-9666 |
13 | Nakajima, M., Irimura, T., Di Ferrante., N. and Nicolson, G. L. (1983) Heparan sulfate degradation: relation to tumor invasive and metastatic properties of mouse B16 melanoma sublines. Science 220: 611-613 DOI PUBMED |
14 | Vaday G. G. and Lider O. (2000) Extracellular matrix moieties, cytokines, and enzymes: dynamic effects on immune cell behavior and inflammation. J. Leukocyte. Biot. 67: 149-159 DOI |
15 | Freeman, C. and Parish, C. R. (1998) Human platelet heparanase: purification, characterization and catalytic activity. Biochem. J. 330: 1341-1350 DOI |
16 | Naparstek, Y., Cohen, I. R., Fuks, Z. and Vlodavsky, I. (1984) Activated T lymphocytes produce a matrix-degrading heparan sulphate endoglycosidase. Nature 310: 241-244 DOI ScienceOn |
17 | Parish, R. C., Hindmarsh, J. E., BartleK, M.R. Staykova, M.A., Cowden, B. W. and Willenborg, O. D. (1998) Treatment of central nervous system inflammation with inhibitors of basement membrane degradation. Immunol. Cell BioI. 76: 104-113 DOI ScienceOn |
18 | Vlodavsky, I., Friedmann, Y, Elkin, M., Aingom, H.,Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz,T., Michal, I., Spector, L. and Pecker, I. (1999) Mammalianheparanase: gene cloning, expression and function in tumorprogression and metastasis. Nature Med. 5: 793-802. DOI ScienceOn |
19 | Bartlett, M. R., Cowden, W. B. and Parish, C. R. (1995) Diffe- rential effects of the anti-inflammatory compounds hepann, mannose-6-phosphate, and castanospermine on degradation of the vascular basement membrane by leukocytes, endothelial cells, and platelets. J. Leukocyte. Biol. 57' 207-213 DOI |
20 | Lindahl, U., Lidholt, K., Spillmann, D. and Kjellen, L. (1994) More to heparin than anticoagulation. Thromb. Res. 75: 1-32 DOI ScienceOn |
21 | Savion, N., Vlodavsky, I. and Fuks, Z. (1984) Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: attachment, invasion, and subsequent degradation of the subendothelial extracellular matrix. J. Cell Physiol. 118: 169-178 DOI |
22 | Sasisekharan, R., Bulmer, M., Moremen, K. W., Cooney, C. L. and Langer, R. (1993) Cloning and expression of heparinase I gene from Flavobacterium heparium. Proc. Natl. Acad. Sci. USA. 90: 3660-3664 DOI ScienceOn |
23 | Nakajima, M., Irimura, T. and Nicolson, G. L. (1988) Heparanases and tumor metastasis. J. Cell. Biochem. 36: 157-167 DOI PUBMED |
24 | Liuzzo, J. P. and Moscatelli, D. (1996) Human leukemia cell lines bind basic fibroblast growth factor (FGF) on FGF receptors and heparan sulfates: downmodulation of FGF receptors by phorbol ester. BIood 87: 244-255 |
25 | Chang, Z., Meyer, K., Rapraeger, A. and Friedl, A. (2000) Differential ability of heparan sulfate proteoglycans to assemble the fibroblast growth factor receptor complex in situ.. FASEB J. 14: 137 -144 DOI |
26 | Paiish, R. C., Freeman, C., Brown, J, K., Francis, J. D. and Cowden, B. W. (1999) Identification of sulfated oligosac-chahde-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity. Canser Res. 59: 3433-3441 |
27 | Jandik, K. A., Gu, K. and Linhardt, R. J. (1994) Action pattern of polysaccharide lyases on glycosaminoglycans. Gtycobiotosy 4: 289-296 |
28 | Vlodavsky, I., Miao, H., Medalion, B., Danagher, P. and Ron, D. (1996) Involvement of heparan sulfate and related molecules in sequestration and growth promoting activity of fibroblast growth factor. Cancer and Metastasis Reviews 15: 177-186 DOI ScienceOn |
29 | Kjellen, L. and Lindahl, U. (1991) Proteoglycans: structures and interactions, Ann. Rev. Biochem. 60: 443-475 DOI ScienceOn |
30 | Takahashi S., Kuzuhara H. and Nakajima M. (2001) Design and synthesis of a heparanase inhibitor with pseudodisacchande structure. Tetrahedron 57: 6915-6926 DOI ScienceOn |
31 | Tyrrel, J.D., Kilfeather, S. and Page, P. C. (1995) Therapeutic uses of heapiin beyond its traditional role as an anticoagulant. Trend in Pharmacol. Science (TiPS) 16: 198-204 DOI ScienceOn |
32 | Ihrcke, N. S., Parker, W., Reissner, K. J. and Platt, J. L. (1998) Regulation of platelet heparanase during inflammation; role of pH and proteinases. J. Cell Physiol. 175: 255-267 DOI ScienceOn |